The Nontrivial Ethics of BrainBiopsies for Research. This Viewpoint advocates for adapting and expanding informed consent protocols for brainbiopsies for research purposes.
Brainbiopsy ManualsLibraryEducationFoundation My CPDPMy Quick Links My RCPA Advanced SearchHomeEventsNews & MediaPathology CareersPathology UpdateAboutContact UsManuals RCPA Manual Pathology Tests B Brain biopsyBRAIN BIOPSYSPECIMEN: Stereotactic aspiration needle biopsy or biopsy from open craniotomy. Laboratory staff should be consulted before the biopsy procedure.METHOD: Fresh tissue
Fluorescein sodium fluorescence: role in stereotactic brainbiopsy. Stereotactic brainbiopsy for eloquent area brain tumours is associated with complications like hemorrhage due to multiple sampling and increased operative time due to dependence on neuropathologist for frozen section assessment. In order to curb these limitations, we investigated the use of Fluorescein sodium fluorescence in confirming pathological tissue samples in stereotactic brainbiopsy of gadolinium-enhancing tumours. This prospective observational study included 23 consecutive patients who underwent stereotactic biopsy of gadolinium-contrast-enhancing brain lesions with intravenous fluorescein sodium administration. 93 specimens were obtained and examined for the presence of fluorescence using a microscope
Post-malaria neurological syndrome (PMNS): a rare case report with brainbiopsy findings. Post-malaria neurological syndrome (PMNS) is a rare, self-limiting condition that presents with a wide range of neurological manifestations after clearance of malarial infection, especially 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 f𝘢𝘭𝘤𝘪𝘱𝘢𝘳𝘶𝘮, most patients recover without residual deficits. Here we present a case and right posterior parasagittal regions, all autoimmune screens, infection workup from blood and CSF were negative, he underwent a brainbiopsy that showed intense perivascular inflammation with neuronal loss and gliosis, findings are nonspecific and can be seen in a variety of condition. The patient's condition improved, and he was discharged without any complications.
Use of MR signal intensity variations to highlight structures at risk along brainbiopsy trajectories. Postoperative intracerebral hemorrhages are significant complications following brain stereotactic biopsy. They can derive from anatomical structure (sulci, vessels) damage that is missed during stereotactic trajectory planning. In this study, the authors investigated the ability to detect
A single-centre study of frame-based stereotactic brainbiopsies. We aimed to evaluate the concordance between the image-based and the tissue-based diagnosis using frame-based stereotactic biopsy. Medical records of biopsy procedures from 2000 to 2017 were reviewed. The radiologists' preoperative reports, biopsy procedures and postoperative histopathological diagnoses were retrieved. We compared
BrainBiopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Brainbiopsy is a useful surgical procedure in the management of patients with suspected neoplastic lesions. Its role in neurologic diseases of unknown etiology remains controversial, especially in ICU patients. This study was undertaken to determine the feasibility , safety, and the diagnostic yield of brainbiopsy in critically ill patients with neurologic diseases of unknown etiology. We also aimed to compare these endpoints to those of non-ICU patients who underwent a brainbiopsy in the same clinical context. Monocenter, retrospective, observational cohort study. A French tertiary center. All adult patients with neurologic diseases of unknown etiology under
Sex, age, and regional differences in CHRM1 and CHRM3 genes expression levels in the human brainbiopsies: potential targets for Alzheimer's disease-related sleep disturbances. Cholinergic hypofunction and sleep disturbance are hallmarks of Alzheimer's disease (AD), a progressive disorder leading to neuronal deterioration. Muscarinic acetylcholine receptor (M1-5 or mAChRs), expressed
Use of fluorescein sodium-assisted intraoperative sample validation to maximize the diagnostic yield of stereotactic brainbiopsy: progress toward a new standard of care? In patients with contraindication to open resection, histological diagnosis is obtained through a stereotactic biopsy (SB). Missed diagnoses and sampling errors are important limitations of SB; therefore, various ways have been
Clinical utility of brainbiopsy for presumed CNS relapse of systemic lymphoma. The objective of this study was to determine the frequency with which brainbiopsy for presumed CNS relapse of systemic hematological malignancies yields new, actionable diagnostic information. Hematological malignancies represent a disparate group of genetic and histopathological disorders. Proclivity for brain involvement is dependent on the unique entity and may occur synchronously or metasynchronously with the systemic lesion. Diffuse large B-cell lymphomas (DLBCLs) have a high propensity for brain involvement. Patients in remission from systemic DLBCL may present with a lesion suspicious for brain relapse. These patients often undergo brainbiopsy. The authors' a priori hypothesis was that brainbiopsy
Severity, timeline, and management of complications after stereotactic brainbiopsy. The literature shows discrepancies in stereotactic brainbiopsy complication rates, severities, and outcomes. Little is known about the timeline of postbiopsy complications. This study aimed to analyze 1) complications following brainbiopsies, using a graded severity scale, and 2) a timeline of complication occurrence. The secondary objectives were to determine factors associated with an increased risk of complications and to assess complication-related management and extra costs. The authors retrospectively examined 1500 consecutive stereotactic brainbiopsies performed in adult patients at their tertiary medical center between April 2009 and April 2019. Three hundred eighty-one biopsies (25.4%) were
Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety. For nonneoplastic neurological diseases, no recommendation exists regarding the place or appropriate timing of brainbiopsy. The aim of this study was to evaluate the diagnostic yield and safety of brainbiopsies from patients with neurological diseases of unknown etiology. We performed a retrospective cohort study from January 1, 2008 to December 31, 2018. We analyzed 1847 brain-biopsied patients, including 178 biopsies indicated for neurological diseases of unknown etiology. Specific histological and final diagnosis rates, positive diagnosis-associated factors, complication rate and complication-associated factors were assessed. Specific histological diagnosis and final diagnosis rates were 71.3
Neuroport® makes brainbiopsy less invasive and easy even in eloquent areas. Tissue diagnosis of brain tumours in eloquent is often done via needle biopsy but this method yields small samples that may not be representative of the whole tumour. The Neuroport system enables a larger tumour biopsy to be taken via a burr hole. We report our experience on 5 cases October 2017 and June 2018
Real-time MR-guided brainbiopsy using 1.0-T open MRI scanner. To evaluate the safety, feasibility and diagnostic performance of real-time MR-guided brainbiopsy using a 1.0-T open MRI scanner. Medical records of 86 consecutive participants who underwent brainbiopsy under the guidance of a 1.0-T open MRI scanner with real-time and MR fluoroscopy techniques were evaluated retrospectively. All of haemorrhage. No serious complications were observed. Real-time MR-guided brainbiopsy using a 1.0-T open MRI scanner is a safe, feasible and accurate diagnostic technique for pathological diagnosis of brain lesions. The procedure duration is shortened and biopsy work flow is simplified. It could be considered as an alternative for brainbiopsy. • Real-time MRI-guided brainbiopsy using a 1.0-T open MRI
The role of brainbiopsy in the clinical management of HIV-related focal brain lesions. Up to 20% of HIV-related focal brain lesion (FBL) diagnoses cannot be determined without invasive procedures. In such cases, brainbiopsy is an important step in the evaluation algorithm. The aims of this study were to describe the clinical outcomes of patients with FBL, the proportion of diagnoses confirmed by brainbiopsies and their aetiologies, and to analyse the proportion of patients in whom the biopsy motivated a change in therapeutic management. A retrospective cohort study was performed. The data from clinical records of patients with HIV-related FBL admitted between January 2005 and December 2015 were reviewed. A total of 137 patients were included in the study. The median age was 39 years
A Case of Diffuse Leptomeningeal Glioneuronal Tumor Misdiagnosed as Chronic Tuberculous Meningitis without BrainBiopsy Here we report a rare case of diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 62-year-old male patient misdiagnosed as having tuberculous meningitis. Due to its rarity and radiologic findings of leptomeningeal enhancement in the basal cisterns on magnetic resonance
Alterations in mitochondria-endoplasmic reticulum connectivity in human brainbiopsies from idiopathic normal pressure hydrocephalus patients Idiopathic normal pressure hydrocephalus (iNPH) is a neuropathology with unknown cause characterised by gait impairment, cognitive decline and ventriculomegaly. These patients often present comorbidity with Alzheimer's disease (AD), including AD that amyloid β-peptide can influence the number of MERCS. MERCS have also been shown to be dysregulated in several neurological pathologies including AD.In this study we have used transmission electron microscopy and show, for the first time, several mitochondria contact sites including MERCS in human brainbiopsies. These unique human brain samples were obtained during neurosurgery from 14 patients
Efficacy, Safety, and Duration of a Frameless Fiducial-Less BrainBiopsy versus Frame-based Stereotactic Biopsy: A Prospective Randomized Study. We compared the efficacy, duration, safety, length of hospital stay of a frameless fiducial-less brainbiopsy with those of the standard frame-based stereotactic biopsy. This prospective cohort study enrolled 56 adult patients: (1) for whom differences between the two methods were found concerning new neurologic symptoms, new abnormal findings in postoperative computed tomography (CT) and length of postoperative hospital stay (LOS). The smallest diameter of a successfully biopsied lesion was 15 mm for both groups. The frameless fiducial-less brainbiopsy was equally efficacious and safe compared with the standard stereotactic frame-based
Brainbiopsy in the diagnosis of leptomeningeal involvement in stage I chronic lymphocytic leukemia Leptomeningeal involvement of CLL is usually underdiagnosed as neurological symptoms are unspecific. It is important to carefully evaluate neurological status in these patients and consider this entity between the differential diagnosis of a neurological deterioration as adequate treatment improves the prognosis. Imaging techniques, analyses of cerebrospinal fluid, and brainbiopsy are useful to establish a definitive diagnosis.
Brainbiopsy to aid diagnosis of neuro-Behçet's disease: Case report and literature review Central nervous system involvement in Behçet's disease (Neuro-Behçet's disease: NBD) has been reported to present diverse clinical and pathological manifestations. A few cases presenting with neurological symptoms preceding other systemic features are difficult to be diagnosed. Here we suggest the clinical benefit of brainbiopsy with a case of NBD initially presenting neurological symptoms.